XETRA · MRK.DE
Merck KGaA
€151.50+€1.20 (+0.8%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.39% below the high.
Loading market information…
OTC · MDGEF · USD
Stock price, earnings
Quote as of May 14, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Medigene AG’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Medigene AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€151.50+€1.20 (+0.8%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.39% below the high.
€78.65-€2.45 (-3.02%)
Abivax S.A.’s quoted price sits in the lower half of its reported 52-week range, 43.42% below the high.
CA$1.82-CA$0.07 (-3.7%)
Anaergia Inc.’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
$4.40$0.00 (0.0%)
Regency Affiliates, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.6% below the high.
CA$0.71CA$0.00 (0.0%)
Accord Financial Corp.’s quoted price sits in the lower half of its reported 52-week range, 79.24% below the high.
£0.00+£0.00 (+9.0%)
Oxford BioDynamics Plc’s quoted price sits in the lower half of its reported 52-week range, 66.18% below the high.
$0.01$0.00 (0.0%)
Ameriguard Security Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.58% below the high.
$0.01$0.00 (0.0%)
ChitogenX Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
